Pick 2–10 funds, stocks or ETFs to see their returns, risk, costs and highlights on one page
| Fund | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| NTRA | +65.40% | −6.42% | −5.13% | −7.66% | +41.51% | +82.81% | +90.48% | +834.45% | +232.07% | +250.79% |
| ES-GENOME | +62.79% | +0.74% | +3.41% | −8.31% | +27.43% | +59.28% | +52.50% | +72.28% | −45.83% | −47.83% |
| SCBGENOME(E) | +65.69% | −0.31% | +2.03% | −8.42% | +25.47% | +56.79% | +56.22% | +88.39% | −44.34% | −46.67% |
| BCARE | +14.91% | +1.99% | +5.09% | +8.23% | +8.14% | +17.30% | +23.16% | +33.14% | +7.17% | +7.49% |
* Fewer than 12 months: the year the fund started reporting NAV, or the current year
Counts only the top holdings with available data, not the whole portfolio · Pick a pair below for details
Excludes NTRA: money market or bond funds, or no holdings data yet
| ES-GENOME | SCBGENOME(E) | |
|---|---|---|
| Held by both | ||
 Twist Bioscience | 10.83% | 10.03% |
 10x Genomics | 10.50% | 8.02% |
 Tempus AI Inc Class A common… | 9.36% | 7.15% |
 CRISPR Therapeutics | 5.49% | 4.20% |
 Absci | 5.30% | 4.05% |
| Personalis | 5.12% | 3.91% |
 Guardant Health | 4.83% | 3.69% |
 Natera | 4.75% | 3.63% |
 Illumina | 4.71% | 3.60% |
 CareDx | 4.55% | 3.48% |
30 Dec 2025 → 2 Nov 2026
| Fund | Return per year | Volatility per year | Sharpe |
|---|---|---|---|
| SCBGENOME(E) | +65.69% | 42.55% | 1.54 |
| ES-GENOME | +62.79% | 42.39% | 1.48 |
| NTRA | +65.40% | 52.61% | 1.24 |
| BCARE | +14.91% | 15.93% | 0.94 |
Sharpe here = annual return ÷ annual volatility, without deducting the risk-free rate, calculated from NAV over the selected period · Periods shorter than 1 year use the cumulative return instead of the annual return
| Drag a column header to reorder | NTRA | ES-GENOME | SCBGENOME(E) | BCARE |
|---|---|---|---|---|
Fund details | ||||
| Fund size | N/A | 225 million | 46.19 million | 4,712 million |
| Inception date | N/A | 23 Mar 2021 | 20 Aug 2021 | 29 Aug 2007 |
| Master fund | N/A | กองทุนที่ลงทุนหลายกอง (ARK Genomic Revolution UCITS, ARK Genomic Revolution, iShares Genomics Immunology and Healthcare) | กองทุน ARK Genomic Revolution ETF | Wellington Global Health Care Equity Fund |
| Dividend policy | N/A | Does not pay | Does not pay | Does not pay |
Risk and currency hedging | ||||
| Risk level | N/A | 7 | 7 | 7 |
| Hedging policy | N/A | Hedged at the manager's discretion | Hedged at the manager's discretion | Hedged at the manager's discretion |
| Share hedged | N/A | 79.06% | 57.68% | 47.41% |
Minimum purchase and redemption | ||||
| First purchase | N/A | 1 THB | 1 THB | 500 THB |
| Subsequent purchase | N/A | 1 THB | 1 THB | 500 THB |
| Redemption (amount) | N/A | 1 THB | 1 THB | No minimum |
| Redemption (units) | N/A | 1 units | No minimum | No minimum |
| Balance (amount) | N/A | No minimum | 1 THB | No minimum |
| Balance (units) | N/A | No minimum | No minimum | No minimum |
Order cut-off and redemption payment | ||||
| Buy before | N/A | 15:30 | 15:30 | 15:30 |
| Redeem before | N/A | 15:30 | 15:30 | 15:30 |
| Redemption paid | N/A | T+4 | T+4 | T+4 |
